| Patents for C07D 281 - Heterocyclic compounds containing rings of more than six members having one nitrogen atom and one sulfur atom as the only ring hetero atoms (1,924) |
|---|
| 01/15/2003 | EP0925287B1 Heterocyclic metalloprotease inhibitors |
| 01/09/2003 | WO2003002147A1 Preventives/remedies for organ functional disorders and organ dysfunction |
| 01/09/2003 | CA2451163A1 Agent for preventing or treating organ functional disorders and order dysfunction |
| 01/08/2003 | EP1025080B1 Process for the recycle of a waste product of diltiazem synthesis |
| 01/07/2003 | US6503898 Administering 4,7-dibenzyl-5,6-dihydroxy-N,N*-di(m-aminobenzyl)--1,3-diazepin-2-one or salt to treat human immunodeficiency virus infection |
| 01/07/2003 | US6503897 N-Formylhydroxylamine derivatives; veterinary medicine; grampositive and gramnegative bacteria |
| 01/03/2003 | WO2003000670A1 A11-piperazinyldibenzo (b, f) (1, 4) oxazepines and thiazepines as atypical antipsychotic agents having low affinity for the d2 receptor |
| 01/03/2003 | WO2002060870A3 Delta agonist analgesics |
| 01/02/2003 | EP1267855A2 Vasopeptidase inhibitors to treat isolated systolic hypertension |
| 12/17/2002 | US6495643 Ring opening polymerization of such as 6-methylene-1,4-dithiepane optionally with methyl methacrylate; minimizing shrinkage; high molecular weight; such as amide, ester or carbonate backbone groups; adhesives, composites, lenses |
| 12/11/2002 | EP1263747A1 1,5-benzothiazepines and their use as hypolipidaemics |
| 12/05/2002 | US20020183307 For therapy of hyperlipidemic condition |
| 12/05/2002 | US20020182253 Sustained-release microgranules containing diltiazem as active principle |
| 12/03/2002 | US6489321 Nonpeptide substituted benzothiazepines as vasopressin antagonists |
| 12/03/2002 | CA2266107C Aralkyl and aralkylidene heterocyclic lactams and imides |
| 11/27/2002 | EP1259499A1 Thiazepinyl hydroxamic acid derivatives as matrix metalloproteinase inhibitors |
| 11/20/2002 | EP1140190B1 Combinations of ileal bile acid transport inhibitors and bile acid sequestering agents for cardiovascular indications |
| 11/20/2002 | EP0593603B1 Bicyclic fibrinogen antagonists |
| 11/19/2002 | CA2138308C Preparation of hexahydroazepinones and hexahydroazepinoles |
| 11/14/2002 | WO2002062324A3 A treatment of oesophageal motility disorders and gastro-oesophageal reflux disease |
| 11/06/2002 | EP1254898A1 Benzene-fused heterocycle derivatives and drugs containing the same as the active ingredient |
| 11/05/2002 | US6476017 (dibenzo(b,e)(1,4)-diazepine-11-yl)benzoic acid derivatives |
| 10/30/2002 | EP1252151A1 A process for the preparation of quetiapine and intermediates therefor |
| 10/30/2002 | EP0775126B1 Hypolipidemic 1,4-benzothiazepine-1,1-dioxides |
| 10/29/2002 | US6472529 Viricides |
| 10/29/2002 | US6472388 Psychotherapeutic agents. |
| 10/29/2002 | CA2068231C Process for the preparation of benzothiazepines by cyclization with phosphonic acids |
| 10/24/2002 | US20020156052 Tricyclic opiod receptor agonists |
| 10/23/2002 | EP1000067B1 Thiazolobenzoheterocycles, preparation and medicines containing same |
| 10/23/2002 | EP0923561B1 Heterocyclic metalloprotease inhibitors |
| 10/23/2002 | CN1093123C Aralkyl and aralkylidene heterocyclic lactams and imides |
| 10/15/2002 | US6465451 Hypolipidemic benzothiazepine compounds |
| 10/10/2002 | WO2002078626A2 Therapeutic combinations for cardiovascular and inflammatory indications |
| 10/10/2002 | WO2002078625A2 Therapeutic combinations for cardiovascular and inflammatory indications |
| 10/10/2002 | US20020147194 Psychological disorders; antiserotonin agents; headache therapy |
| 10/10/2002 | US20020147186 Side effect reduction |
| 10/10/2002 | CA2442328A1 Therapeutic combinations for cardiovascular and inflammatory indications |
| 10/09/2002 | EP1246837A2 Oligomers of nonpeptide restricted mimetics of dipeptides or tripeptides and the use thereof in the synthesis of synthetic proteins and polypeptides |
| 10/09/2002 | EP0683774B1 Hypolipidaemic compounds |
| 10/08/2002 | CA2172354C Benzazepine-, benzoxazepine- and benzothiazepine-n-acetic acid derivatives, process for their preparation and pharmaceutical compositions containing them |
| 10/02/2002 | EP0679641B1 Sulfonamide and sulfonic ester derivatives each having tricyclic hetero ring |
| 09/04/2002 | EP1235792A1 Preparation of [4s-(4alpha,7alpha,10abeta)]-4-amino-octahydro-5-oxo-7h-pyrido 2,1-b] 1,3]thiazepine-7-carboxylic acid, methyl ester and salts thereof via novel disulfides |
| 09/04/2002 | CN1367782A Process for producing dibenzothiazepine derivatives |
| 08/27/2002 | US6441165 Process for the preparation of 11-amino-3-chloro-6, 11-dihydro-5, 5-dioxo-6-methyl-dibenzo[c,f][1,2]thiazepine and application to the synthesis of tianeptine |
| 08/22/2002 | WO2002024204A3 Treatment of diabetes mellitus by inhibition of mitochondrial calcium/sodium antiporter |
| 08/22/2002 | WO1999063992A9 Novel calcium channel drugs and uses |
| 08/15/2002 | WO2002062346A1 Method of treating substance abuse with quetiapine |
| 08/15/2002 | WO2002062324A2 A treatment of oesophageal motility disorders and gastro-oesophageal reflux disease |
| 08/15/2002 | CA2437380A1 A treatment of oesophageal motility disorders and gastro-oesophageal reflux disease |
| 08/08/2002 | WO2002060870A2 Delta agonist analgesics |
| 08/08/2002 | WO2002008211A3 Benzothiazepines and their use as antihyperlipidemics |
| 08/08/2002 | US20020107406 Calcium receptor-active compounds |
| 07/31/2002 | EP1226132A1 Nonpeptide substituted benzothiazepines as vasopressin antagonists |
| 07/25/2002 | US20020099084 Pharmaceutically active compounds and methods of use |
| 07/24/2002 | EP1223939A1 Method of treating weight gain |
| 07/23/2002 | US6423708 Aralkyl and aralkylidene heterocyclic lactams and imides |
| 07/11/2002 | WO2002053548A1 Benzothiazepine derivatives |
| 07/11/2002 | US20020091119 Aralkyl and aralkylidene heterocyclic lactams and imides |
| 07/11/2002 | US20020091118 Psychotherapeutic agents. |
| 07/11/2002 | US20020091117 Psychotherapeutic agents. |
| 07/04/2002 | WO2002051838A1 Novel benzazepines and related heterocyclic derivatives which are useful as orexin receptor antagonists |
| 07/04/2002 | WO2002051232A2 Novel benzazepines and related heterocyclic derivatives |
| 07/03/2002 | EP1218010A2 1,4-benzothiazepines to treat obesity related disorders |
| 07/02/2002 | USRE37781 Substituted cyclic carbonyls and derivatives thereof useful as retroviral protease inhibitors |
| 06/27/2002 | WO2002050051A1 Chemical compounds |
| 06/27/2002 | WO2002049652A1 Method of treatment |
| 06/27/2002 | US20020082193 Inhibition of mitochondrial calcium/sodium antiporter |
| 06/25/2002 | CA2098114C A process for the preparation of diltiazem |
| 06/13/2002 | WO2002046167A1 Benzyl (idene)-lactams and their use as 5ht1-receptor ligands |
| 06/13/2002 | US20020072519 Useful as psychotherapeutic agents |
| 06/13/2002 | CA2435467A1 Benzyl (idene)-lactams and their use as 5ht1-receptor ligands |
| 06/11/2002 | US6403592 Serotonin reuptake inhibitors |
| 06/04/2002 | US6399598 Diheterocyclic metalloprotease inhibitors |
| 05/23/2002 | WO2001074348A8 Vasopeptidase inhibitors to treat isolated systolic hypertension |
| 05/10/2002 | WO2000071106A3 Method of treating weight gain |
| 05/08/2002 | EP1203769A1 Hypolipidemic 1,4-benzothiazepine derivative |
| 05/07/2002 | US6383516 Sustained-release microgranules containing diltiazem as active principle |
| 05/02/2002 | EP1201663A1 Process for producing dibenzothiazepine derivatives |
| 04/30/2002 | US6380186 Psychotherapeutic agents |
| 04/30/2002 | CA2059787C Hydrazine derivative and pesticidal composition comprising said derivative as an effective ingredient |
| 04/25/2002 | US20020049214 Aralkyl and aralkylidene heterocyclic lactams and imides as selective agonists and antagonists of serotonin 1 (5-HT1) recepor, used in treating hypertension and all forms of depression |
| 04/24/2002 | CN1346352A 1-4-benzothiazepine-1,1-dioxide derivatives substituted by sugar radicals, methods for the production thereof, medicaments containing these compounds and the use thereof |
| 04/24/2002 | CN1346351A 1,2-benzothiazepines for the treatment of hyperlipidemic diseases |
| 04/17/2002 | CN1345308A Acetylenic alpha-amino acid based sulfonamide hydroxamic acid TACE inhibitors |
| 04/16/2002 | US6372734 Crystalline dibenzothiazepine derivative and its use as an antipsychotic agent |
| 04/16/2002 | US6372733 Hexahydro-5-imino-1,4-1,4-thiazepine derivatives as inhibitors of nitric oxide synthases |
| 04/11/2002 | WO2001000185A3 1,4-denzothiazepines to treat obesity related disorders |
| 04/09/2002 | US6369221 Anticonvulsants, antiischemic agents; brain and nervous system disorder treatment |
| 04/02/2002 | US6365587 Substituted aryl hydroxamic acids as metalloproteinase inhibitors |
| 03/28/2002 | WO2002024204A2 Treatment of diabetes mellitus by inhibition of mitochondrial calcium/sodium antiporter |
| 03/28/2002 | CA2422671A1 Treatment of diabetes mellitus by inhibition of mitochondrial calcium/sodium antiporter |
| 03/26/2002 | US6362231 Calcium receptor active compounds |
| 03/26/2002 | CA2032498C Novel 8-substituted-2-aminotetralines |
| 03/19/2002 | US6358993 Pharmaceutically active nitrogen ring compounds and methods of use thereof |
| 03/14/2002 | WO2002020019A1 New use of quetiapine |
| 03/14/2002 | US20020032187 Method for stimulating bone formation |
| 03/06/2002 | EP0906907B1 Compounds potentiating retinoid |
| 03/06/2002 | CN1338945A Combination of ileal bile acid transport inhibitors and bile acid sequestring agents for cardiovascular indications |
| 03/05/2002 | US6352982 4,1-benzoxazepines, their analogues, and their use as somatostatin agonists |
| 02/27/2002 | CN1337955A Substituted 2-arylimino heterocycles and compositions containing them, for use as progesterone receptor binding agents |